Walgreens Boots AllianceAfter the increase in winter-related demand for booster shots, and testing during winter months with the Covid-19 omicron variety, Thursday’s fiscal second-quarter earnings exceeded all analysts’ expectations.

It reiterated its year-end outlook. The drugstore chain stated that the adjusted earnings per share would rise in the single digits.

The shares fell by 1% In premarket trading

This is what Walgreens reported, compared to what analysts expected for its second quarter ending February 28, 2008. Based on Refinitiv Data:

• Earnings per Share: $1.59 Adjusted vs. Expected $1.40
• Revenue: 3.76 billion, vs. the $33.4 billion anticipated

Net income decreased to $883million, which is $1.02 per share in the fourth quarter. In the past year, it was $1.03 billion or $1.19 a share.

The earnings of the company, which excludes items, exceeded $1.59 per share. Refinitiv surveyed analysts to estimate that $1.40 was expected.

33.76 billion was the lowest level of sales The increase in sales was a little more than the $32.78 billion analysts predicted a year ago, however it is still higher than that of last year.

Walgreens stock is down 9.9% this year as of Wednesday’s closing. The closing share price of Walgreens was $47.46 on Wednesday, which brings its market capitalization to $40.97 million.

This is a developing story. Keep checking back for more updates.